SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-074231
Filing Date
2024-06-17
Accepted
2024-06-17 16:05:01
Documents
13
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20240611.htm   iXBRL 8-K 41395
2 EX-99.1 agen-ex99_1.htm EX-99.1 15921
3 GRAPHIC img250783414_0.jpg GRAPHIC 1981
  Complete submission text file 0000950170-24-074231.txt   175644

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20240611.xsd EX-101.SCH 23892
16 EXTRACTED XBRL INSTANCE DOCUMENT agen-20240611_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 241048174
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)